BamSEC and AlphaSense Join Forces
Learn More

Translate Bio, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 8 pages Consulting Agreement
12/34/56
EX-10.2
from 10-Q 9 pages On Behalf of Translate Bio, Inc., a Delaware Corporation (The “Company”), I Am Pleased to Offer You the Position of the Company’s Chief Financial Officer & Corporate Strategy. Please Note This Offer Is Also Contingent Upon the Successful Completion of References and Routine Background Checks and Work Authorization
12/34/56
EX-10.1
from 10-Q 3 pages Translate Bio, Inc. Second Amended and Restated Director Compensation Policy Adopted on June 16, 2021
12/34/56
EX-10.4
from 10-Q 8 pages March 11, 2020 Paul Burgess Re: Amended and Restated Employment Agreement Dear Paul
12/34/56
EX-10.3
from 10-Q 8 pages March 11, 2020 Ann Barbier Re: Amended and Restated Employment Agreement Dear Ann
12/34/56
EX-10.2
from 10-Q 9 pages Re: Employment Agreement Dear Rand: On Behalf of Translate Bio, Inc., a Delaware Corporation (The “Company”), I Am Pleased to Offer You the Position of the Company’s President. Please Note This Offer Is Also Contingent Upon the Successful Completion of References and Routine Background Checks and Work Authorization
12/34/56
EX-10.1
from 10-Q 3 pages Translate Bio, Inc. First Amended and Restated Director Compensation Policy
12/34/56
EX-10.22
from 10-K 7 pages Via Electronic Mail December 27, 2020 Dear John: • as of the Separation Date, All Salary Payments From the Company Will Cease and Any Benefits You Had as of the Separation Date Under Company-Provided Benefit Plans, Programs, or Practices Will Terminate, Except as Required by Federal or State Law. • You Will Receive on the Separation Date Payment for Your Final Wages and Any Unused Vacation Time Accrued Through the Separation Date. • You May, if Eligible and at Your Own Cost, Elect to Continue Receiving Group Medical Insurance Pursuant to the “Cobra” Law. Please Consult the Cobra Materials to Be Provided Under Separate Cover for Details Regarding These Benefits
12/34/56
EX-10.18
from 10-K 91 pages 200 West Street Waltham, Massachusetts Lease Dated November 3, 2020
12/34/56
EX-10.14
from 10-K 7 pages Translate Bio, Inc. Nonstatutory Stock Option Agreement Granted Under 2021 Inducement Stock Incentive Plan
12/34/56
EX-10.13
from 10-K 7 pages Translate Bio, Inc. Nonstatutory Stock Option Agreement Granted Under 2021 Inducement Stock Incentive Plan
12/34/56
EX-10.12
from 10-K 6 pages Translate Bio, Inc. Nonstatutory Stock Option Agreement Granted Under 2021 Inducement Stock Incentive Plan
12/34/56
EX-10.11
from 10-K 14 pages Translate Bio, Inc. 2021 Inducement Stock Incentive Plan
12/34/56
EX-10.1
from 10-Q 10 pages Amendments
12/34/56
EX-10.5
from 10-Q 2 pages Certain Identified Information Has Been Marked in the Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company, if Publicly Disclosed. Double Asterisks Denote Omissions. Third Amendment
12/34/56
EX-10.4
from 10-Q 11 pages Certain Identified Information Has Been Marked in the Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company, if Publicly Disclosed. Double Asterisks Denote Omissions. Supply Agreement
12/34/56
EX-10.3
from 10-Q 18 pages Registration Rights Agreement
12/34/56
EX-10.2
from 10-Q 46 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 21 pages Certain Identified Information Has Been Marked in the Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company, if Publicly Disclosed. Double Asterisks Denote Omission. Second Amendment to the Collaboration and License Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Certain Identified Information Has Been Marked in the Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm to the Company, if Publicly Disclosed. Double Asterisks Denote Omissions
12/34/56